"SALT Trial Study of Ascending Levels of Tolvaptan in Hyponatremia"

PHASE3CompletedINTERVENTIONAL
Enrollment

240

Participants

Timeline

Start Date

April 30, 2003

Study Completion Date

February 28, 2006

Conditions
HyponatremiasWater IntoxicationInappropriate ADH SyndromeWater-Electrolyte Imbalances
Interventions
DRUG

tolvaptan

Trial Locations (23)

10010

New York

15213

University of Pittsburgh Medical Center, Pittsburgh

19401

The Arthur P. Noyes Research Foundation, Norristown

27599

University of North Carolina, Div. of Cardiology, Chapel Hill

30912

Medical College of Georgia, Augusta

32610

University of Florida Gainesville, Gainesville

33952

Charlotte Heart Group Research Ctr, Port Charlotte

37388

Tennessee Center for Clinical Trials, Tullahoma

38120

Baptist Clinical Research Ctr, Memphis

43210

Ohio State University Medical Center, Columbus

44106

University Hospitals of Cleveland, Cleveland

52242

University of Iowa Hospital, Iowa City

55417

Minneapolis VA Medical Center, Minneapolis

59701

Mercury Street Medical, Butte

60611

Northwestern University, Chicago

60637

University of Chicago, Chicago

63110

Washington University Ctr for Clinical Studies, St Louis

80218

Aurora Denver Cardiology Association, Denver

80262

University of Colorado Heath Science Center, Denver

90073

VA Greater Los Angeles Health Care Ctr, Los Angeles

93552

UCLA, Los Angeles

94143

UCSF Medical Center, San Francisco

Unknown

Northshore University Hospital, Great Neck

Sponsors
All Listed Sponsors
collaborator

Otsuka Pharmaceutical Co., Ltd.

INDUSTRY

lead

Otsuka Pharmaceutical Development & Commercialization, Inc.

INDUSTRY